NASDAQ · Medical - Devices

SIBN (SIBN) Stock

$18.45 +3.89% NASDAQ: SIBN Healthcare

Valuation

MetricValue
Price$18.45
Market Cap$818.24M
P/E Ratio-33.73
P/B Ratio3.70
P/S Ratio3.18
EPS (TTM)$-0.44
52-Week High$21.89
52-Week Low$11.48
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-10.67%
ROA-7.95%
ROCE-12.36%
Gross Margin-10.95%
Operating Margin-10.95%
Net Margin-8.10%
Debt/Equity0.04
Current Ratio8.64

Annual Financials (USD)

Metric20212022202320242025
Revenue$90.0M$106.0M$139.0M$167.0M$201.0M
Operating Profit$-52.0M$-60.0M$-47.0M$-35.0M$-22.0M
Net Profit$-57.0M$-61.0M$-43.0M$-31.0M$-19.0M
EPS$-1.71$-1.79$-1.13$-0.75$-0.44
Op Margin-57.3%-56.0%-33.8%-21.1%-11.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$191.0M$158.0M$230.0M$230.0M$239.0M
Total Liabilities$56.0M$59.0M$61.0M$63.0M$61.0M
Cash$63.0M$21.0M$33.0M$35.0M$42.0M
Borrowings$40.0M$39.0M$39.0M$37.0M$1.0M

Latest News

SI-BONE To Report Second Quarter 2026 Financial Results on August 3, 2026 GlobeNewswire · Jul 20, 2026 Truist Securities Adjusts Price Target on SI-BONE to $21 From $18, Maintains Buy Rating MT Newswires · Jul 16, 2026 ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board GlobeNewswire · Jul 14, 2026 SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026 GlobeNewswire · Jun 4, 2026 Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now Zacks · Jun 3, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-40.0M$-42.0M$-19.0M$-12.0M$-1.0M
Investing Cash Flow$45.0M$-12.0M$-68.0M$2.0M$-4.0M
Financing Cash Flow$0$0$7.0M$2.0M$0
Net Cash Flow$10.0M$-43.0M$13.0M$2.0M$7.0M
Free Cash Flow$-46.0M$-51.0M$-27.0M$-23.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-0.84%
Quick Ratio8.34
Interest Coverage-4.40
Return 1Y-7.26%
Return 3Y-34.25%
Return 5Y-41.39%

Ownership

Insiders Held3.42%
Institutions Held107.13%
Institutions Float Held110.92%
Institutional HolderSharesReport Date
First Light Asset Management, LLC5,353,1902026-03-31
Blackrock Inc.3,428,5412026-03-31
American Century Companies Inc2,509,0652026-03-31
Brown Advisory Inc.2,122,3322026-03-31
Cadian Capital Management, LP1,887,4722026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About SIBN

SIBN is led by CEO Laura A. Francis, employs 349 people, headquartered in US, publicly traded since 2018.

SIBN stock trades at $18.45 with a market capitalization of $818.24M. The stock is valued at a price-to-earnings (P/E) ratio of -33.73, price-to-book of 3.70, price-to-sales of 3.18. Over the past 52 weeks the stock has ranged between $11.48 and $21.89, and currently trades 15.7% below its 52-week high.

On profitability, SIBN generates a return on equity (ROE) of -10.67%, return on capital employed of -12.36%, an operating margin of -10.95%, a net profit margin of -8.10%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides